XTLB - XTL Biopharmaceuticals Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development443578278
Selling General and Administrative1,2701,4291,744
Non Recurring8481,6041,604
Total Operating Expenses---
Operating Income or Loss-2,561-3,611-2,022
Income from Continuing Operations
Total Other Income/Expenses Net23410
Earnings Before Interest and Taxes-2,538-3,607-2,012
Interest Expense715107
Income Before Tax-2,545-3,622-2,119
Income Tax Expense---
Minority Interest--19
Net Income From Continuing Ops-2,545-3,622-2,119
Non-recurring Events
Discontinued Operations--689-746
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,545-4,311-2,865
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,545-4,311-2,865